
News from go2.org
We’ve assigned a rating of Unknown factuality to go2.org. You can read more about how we’ve determined go2.org’s credibility and reliability as a news source here: https://groundnews.lakegeneva.lib.wi.us/rating-system.
Media Bias Ratings
Do you diasgree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top go2.org News

Obamacare · United StatesThe Supreme Court on Friday rejected a challenge to an Affordable Care Act provision that set up a panel to recommend preventive care services that insurers must provide at no cost to patients.See the Story
Supreme Court endorses Obamacare panel that requires free preventive care
56% Center coverage: 149 sources

Donald TrumpHouse continues debate on big, beautiful bill WEST VIRGINIA (WBOY) — Following Tuesday's passage of the Budget Reconciliation Bill, aka the "One Big, Beautiful Bill," in the U.S. Senate, the American Civil Liberties Union of West Virginia (ACLU-WV) is warning that multiple West Virginia hospitals could close if the bill passes the House as well. In a social media post on Wednesday, the ACLU-WV warned that cuts to Medicaid funding outlined in the…See the Story
ACLU Says 7 West Virginia Hospitals Would Close if 'Big, Beautiful Bill' Passes
42% Right coverage: 24 sources

Pharma · United StatesFDA grants accelerated approval to AstraZeneca's Datroway for EGFR-mutant NSCLC after prior therapies, with a 45% response rate and a $45 million milestone due.See the Story
FDA Approves AstraZeneca And Daiichi Sankyo's Datroway For EGFR-Mutated Lung Cancer - AstraZeneca (NASDAQ:AZN)
75% Center coverage: 4 sources
A Mother and Son on a Mission: Rina’s Story - GO2 for Lung Cancer
Next-Generation TKI Approved for Advanced ROS1-Positive Lung Cancer
100% Center coverage: 2 sources